Kyle Rose
Stock Analyst at Canaccord Genuity
(2.65)
# 2,197
Out of 4,996 analysts
114
Total ratings
53.26%
Success rate
13.79%
Average return
Main Sectors:
Stocks Rated by Kyle Rose
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SNN Smith & Nephew | Maintains: Hold | $27 | $35.42 | -23.77% | 6 | Feb 26, 2025 | |
| PODD Insulet | Maintains: Buy | $304 → $324 | $318.00 | +1.89% | 16 | Feb 21, 2025 | |
| SYK Stryker | Maintains: Buy | $420 → $435 | $369.02 | +17.88% | 20 | Jan 29, 2025 | |
| GMED Globus Medical | Maintains: Buy | $67 → $71 | $55.70 | +27.47% | 7 | Dec 20, 2023 | |
| ENOV Enovis | Maintains: Buy | $65 → $71 | $29.99 | +136.75% | 3 | Dec 20, 2023 | |
| INMD InMode | Downgrades: Hold | $55 → $22 | $14.90 | +47.65% | 10 | Oct 13, 2023 | |
| SKIN The Beauty Health Company | Assumes: Buy | $10 | $1.97 | +407.61% | 4 | Aug 25, 2023 | |
| ATEC Alphatec Holdings | Maintains: Buy | $17 → $22 | $15.02 | +46.47% | 4 | Aug 4, 2023 | |
| DXCM DexCom | Maintains: Buy | $135 → $150 | $67.10 | +123.55% | 17 | Jul 28, 2023 | |
| RBOT Vicarious Surgical | Maintains: Buy | $360 → $270 | $5.46 | +4,845.05% | 3 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $27 | $14.04 | +92.31% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.43 | +948.22% | 1 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $17.16 | -12.59% | 6 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $125 → $122 | $167.73 | -27.26% | 1 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $3 → $4 | $3.95 | +1.39% | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $6.66 | - | 2 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $165 → $125 | $98.24 | +27.24% | 7 | Feb 8, 2022 |
Smith & Nephew
Feb 26, 2025
Maintains: Hold
Price Target: $27
Current: $35.42
Upside: -23.77%
Insulet
Feb 21, 2025
Maintains: Buy
Price Target: $304 → $324
Current: $318.00
Upside: +1.89%
Stryker
Jan 29, 2025
Maintains: Buy
Price Target: $420 → $435
Current: $369.02
Upside: +17.88%
Globus Medical
Dec 20, 2023
Maintains: Buy
Price Target: $67 → $71
Current: $55.70
Upside: +27.47%
Enovis
Dec 20, 2023
Maintains: Buy
Price Target: $65 → $71
Current: $29.99
Upside: +136.75%
InMode
Oct 13, 2023
Downgrades: Hold
Price Target: $55 → $22
Current: $14.90
Upside: +47.65%
The Beauty Health Company
Aug 25, 2023
Assumes: Buy
Price Target: $10
Current: $1.97
Upside: +407.61%
Alphatec Holdings
Aug 4, 2023
Maintains: Buy
Price Target: $17 → $22
Current: $15.02
Upside: +46.47%
DexCom
Jul 28, 2023
Maintains: Buy
Price Target: $135 → $150
Current: $67.10
Upside: +123.55%
Vicarious Surgical
May 31, 2023
Maintains: Buy
Price Target: $360 → $270
Current: $5.46
Upside: +4,845.05%
May 2, 2023
Maintains: Buy
Price Target: $24 → $27
Current: $14.04
Upside: +92.31%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $1.43
Upside: +948.22%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $17.16
Upside: -12.59%
Mar 1, 2023
Maintains: Market Perform
Price Target: $125 → $122
Current: $167.73
Upside: -27.26%
Nov 10, 2022
Upgrades: Buy
Price Target: $3 → $4
Current: $3.95
Upside: +1.39%
Nov 9, 2022
Downgrades: Hold
Price Target: n/a
Current: $6.66
Upside: -
Feb 8, 2022
Downgrades: Hold
Price Target: $165 → $125
Current: $98.24
Upside: +27.24%